Celularity Stock Performance
| CELU Stock | USD 2.04 0.03 1.49% |
On a scale of 0 to 100, Celularity holds a performance score of 2. The firm shows a Beta (market volatility) of 1.0, which signifies a somewhat significant risk relative to the market. Celularity returns are very sensitive to returns on the market. As the market goes up or down, Celularity is expected to follow. Please check Celularity's downside variance, and the relationship between the sortino ratio and accumulation distribution , to make a quick decision on whether Celularity's price patterns will revert.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Celularity are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Celularity unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.49 | Five Day Return (28.42) | Year To Date Return (27.14) | Ten Year Return (97.92) | All Time Return (97.92) |
Last Split Factor 1:10 | Last Split Date 2024-02-29 |
1 | Acquisition by Smith Robin L of 199921 shares of Celularity subject to Rule 16b-3 | 10/07/2024 |
2 | Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound Product from Sequence LifeScience, Inc. | 10/16/2024 |
3 | Celularity Inc. Receives Notice from Nasdaq Confirms Intention to File an Appeal | 10/18/2024 |
4 | Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel | 10/23/2024 |
5 | Celularity Raises Full Year 2024 Guidance asExpected Net Sales Through October Reach 44.4 Million | 11/07/2024 |
6 | Celularity announces resolution of Nasdaq listing compliance matter | 11/18/2024 |
7 | Celularity announces receipt of Nasdaq notification | 11/27/2024 |
| Begin Period Cash Flow | 28.8 M |
Celularity |
Celularity Relative Risk vs. Return Landscape
If you would invest 286.00 in Celularity on September 3, 2024 and sell it today you would lose (82.00) from holding Celularity or give up 28.67% of portfolio value over 90 days. Celularity is currently generating 0.4817% in daily expected returns and assumes 16.6766% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Celularity, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Celularity Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Celularity's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Celularity, and traders can use it to determine the average amount a Celularity's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0289
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CELU | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 16.68 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.48 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Celularity is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Celularity by adding it to a well-diversified portfolio.
Celularity Fundamentals Growth
Celularity Stock prices reflect investors' perceptions of the future prospects and financial health of Celularity, and Celularity fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Celularity Stock performance.
| Return On Equity | -1.54 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (2.64) % | ||||
| Operating Margin | (0.84) % | ||||
| Current Valuation | 111.78 M | ||||
| Shares Outstanding | 22.01 M | ||||
| Price To Earning | 3.08 X | ||||
| Price To Book | 1.61 X | ||||
| Price To Sales | 1.05 X | ||||
| Revenue | 22.77 M | ||||
| Gross Profit | (1.69 M) | ||||
| EBITDA | (35.91 M) | ||||
| Net Income | (196.29 M) | ||||
| Cash And Equivalents | 42.65 M | ||||
| Cash Per Share | 0.29 X | ||||
| Total Debt | 39.24 M | ||||
| Debt To Equity | 0.41 % | ||||
| Current Ratio | 0.91 X | ||||
| Book Value Per Share | 1.27 X | ||||
| Cash Flow From Operations | (38.69 M) | ||||
| Earnings Per Share | (104.78) X | ||||
| Market Capitalization | 44.89 M | ||||
| Total Asset | 143.89 M | ||||
| Retained Earnings | (841.79 M) | ||||
| Working Capital | (47.51 M) | ||||
About Celularity Performance
Assessing Celularity's fundamental ratios provides investors with valuable insights into Celularity's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Celularity is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 131.11 | 230.82 | |
| Return On Tangible Assets | (1.56) | (1.49) | |
| Return On Capital Employed | (2.51) | (2.39) | |
| Return On Assets | (1.36) | (1.30) | |
| Return On Equity | (4.79) | (4.55) |
Things to note about Celularity performance evaluation
Checking the ongoing alerts about Celularity for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Celularity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Celularity had very high historical volatility over the last 90 days | |
| Celularity has a very high chance of going through financial distress in the upcoming years | |
| Celularity currently holds 39.24 M in liabilities with Debt to Equity (D/E) ratio of 0.41, which is about average as compared to similar companies. Celularity has a current ratio of 0.89, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Celularity's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 22.77 M. Net Loss for the year was (196.29 M) with loss before overhead, payroll, taxes, and interest of (1.69 M). | |
| Celularity currently holds about 42.65 M in cash with (38.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. | |
| Roughly 50.0% of Celularity shares are held by company insiders | |
| Latest headline from seekingalpha.com: Celularity announces receipt of Nasdaq notification |
- Analyzing Celularity's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Celularity's stock is overvalued or undervalued compared to its peers.
- Examining Celularity's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Celularity's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Celularity's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Celularity's stock. These opinions can provide insight into Celularity's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.